ToxStrategies is a multidisciplinary scientific consulting firm that strives to develop innovative solutions to address the scientific, technical, and regulatory challenges confronting our clients. We have a reputation for applying sound science and novel approaches tailored to meet the specific needs of our clients, whether a rapid response or a comprehensive analysis is required.

Latest News

Growing Need for Cumulative Exposure and Cumulative Risk Assessment

Understanding the Full Picture of Chemical and Environmental Exposures Regulators, industry, and the public are increasingly focused on the combined effects of multiple chemicals and environmental stressors on human health. Recently, the Make Our Children Healthy Again Assessment The MAHA Report – The White House identified exposure to an “aggregation of environmental chemicals” and exposure to food additives among the key drivers behind child health issues. Traditional “aggregate” risk assessments have estimated exposures to individual chemicals read more…

13 State AG’s Issue Guidance – Environmental Justice Initiatives Remain Necessary and Legal

Multi-State Guidance Affirming the Importance and Legality of Environmental Justice Initiatives   The Attorneys General of California, Massachusetts, and New York, joined by the Attorneys General of Arizona, Connecticut, Delaware, Hawaii, Illinois, Maryland, Minnesota, Oregon, Rhode Island, and Vermont, issue this Guidance to affirm the importance and legality of efforts to advance environmental justice, which seek a healthy environment for all people across the United States in which to live, play, work, learn, and worship. read more…

MTAP is a promising target for cancer therapy.

EpidStrategies’ scientists Mina Suh, Naimisha Movva, and Sue Pastula have authored a new systematic literature review in Cancer Treatment and Research Communications. This review summarizes the prevalence of MTAP deletions or loss of expression and accompanying prognostic impacts in adult and pediatric patients with specific solid or hematologic cancers. This systematic literature review is the first to comprehensively describe and summarize current MTAP evidence across several solid and hematologic cancers. High prevalence of MTAP homozygous deletions or loss of protein expression read more…

Latest Publications

Borghoff SJ, Heintz MM, Rivera BN, Haws L, Thompson C. 2025. Evaluation of an anti-thyroid mode of action for thyroid follicular cell adenomas in female mice exposed to tertiary butyl alcohol. Regul Toxicol Pharmacol 105936;  doi: 10.1016/j.yrtph.2025.105936. Online ahead of print Sept. 4, 2025. PMID: 40914479.

View Abstract

Shaw J, Hsu H, Tu H, Chia V, Aggarwal S, Carrigan G, Kelsh MA. Immortal time bias impacts time-to-time event outcomes in cohort with genomic testing. Abstract 6F-03, International Society for Pharmacoepidemiology (ISPE) 41st Annual Meeting, Washington, DC, August 2025.

View Abstract
More Publications

Industry Expertise

0
Technical Staff
0
Staff with Doctoral Degrees
0 %
Percent of technical staff with advanced degrees
0
Professional Certifications
0
Peer-Reviewed Publications
0
Pharma IND, CTA, NDA, BLA, MAA
0
Published Systematic Literature Reviews
GRAS Dossiers

Divisions of ToxStrategies